华绿生物：二级市场股价影响因素较多

Core Viewpoint - The company, Hualu Bio, reassured investors about its commitment to accurate and complete information disclosure, emphasizing that its production and operations are normal, and management remains confident in the company's development [2] Group 1 - The company responded to investor inquiries on November 4, indicating that its information disclosure is truthful, accurate, and complete [2] - The company acknowledged that various factors influence its stock price in the secondary market and urged investors to maintain a correct perspective [2] - Management expressed strong confidence in the company's future growth and development [2]